Advanced MRI: Translation from Animal to Human in Brain Tumor Research

Neuroimaging Clinics of North America

Volumn 19, Issue 4, 2009, Pages 517-526

  Moffat, Bradford A ^a   Galbán, Craig J ^b   Rehemtulla, Alnawaz ^b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Brain tumor; Diffusion MRI; Imaging biomarkers; Magnetic resonance spectroscopy (MRS); Perfusion MRI; Translational research

Indexed keywords

CHOLINE; CREATINE; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID; VASCULOTROPIN A;

BRAIN TUMOR; CANCER RESEARCH; CANCER THERAPY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; NEUROIMAGING; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REVIEW; TUMOR BLOOD FLOW; VALIDATION PROCESS;

ANIMALS; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; TRANSLATIONAL RESEARCH; TUMOR MARKERS, BIOLOGICAL;

EID: 70549108190     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2009.08.008     Document Type: Review

References (51)

1. Young G.S. Advanced MRI of adult brain tumors. Neurol Clin 25 4 (2007) 947-973 viii
2. Jenkinson M.D., Du Plessis D.G., Walker C., et al. Advanced MRI in the management of adult gliomas. Br J Neurosurg 21 6 (2007) 550-561
3. Rudin M., Beckmann N., Porszasz R., et al. In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives. NMR Biomed 12 2 (1999) 69-97
4. Galbraith S.M. MR in oncology drug development. NMR Biomed 19 6 (2006) 681-689
5. Ross B.D., Chenevert T.L., Moffat B.A., et al. Use of Magnetic Resonance Imaging (MRI) for evaluation treatment response. In: Holland E.C. (Ed). Mouse models of human cancer (2004), Wiley-Liss, Hoboken (NJ) 377-390
6. Koo V., Hamilton P.W., and Williamson K. Noninvasive in vivo imaging in small animal research. Cell Oncol 28 4 (2006) 127-139
7. Evelhoch J., Garwood M., Vigneron D., et al. Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report. Cancer Res 65 16 (2005) 7041-7044
8. Padhani A.R., Liu G., Koh D.M., et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11 2 (2009) 102-125
9. Frey H.E., Knispel R.R., Kruuv J., et al. Proton spin-lattice relaxation studies of nonmalignant tissues of tumorous mice. J Natl Cancer Inst 49 3 (1972) 903-906
10. Hawkes R.C., Holland G.N., Moore W.S., et al. Nuclear magnetic resonance (NMR) tomography of the brain: a preliminary clinical assessment with demonstration of pathology. J Comput Assist Tomogr 4 5 (1980) 577-586
11. Katz R. Biomarkers and surrogate markers: an FDA perspective. NeuroRx 1 2 (2004) 189-195
12. Kelloff G.J., and Sigman C.C. New science-based endpoints to accelerate oncology drug development. Eur J Cancer 41 4 (2005) 491-501
13. Aisen A.M., and Chenevert T.L. MR spectroscopy: clinical perspective. Radiology 173 3 (1989) 593-599
14. Chapman J.D. The detection and measurement of hypoxic cells in solid tumors. Cancer 54 11 (1984) 2441-2449
15. Evanochko W.T., Ng T.C., and Glickson J.D. Application of in vivo NMR spectroscopy to cancer. Magn Reson Med 1 4 (1984) 508-534
16. Koeze T.H., Lantos P.L., Iles R.A., et al. In vivo nuclear magnetic resonance spectroscopy of a transplanted brain tumour. Br J Cancer 49 3 (1984) 357-361
17. Bruhn H., Frahm J., Gyngell M.L., et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 172 2 (1989) 541-548
18. Remy C., Von Kienlin M., Lotito S., et al. In vivo 1H NMR spectroscopy of an intracerebral glioma in the rat. Magn Reson Med 9 3 (1989) 395-401
19. Pfeuffer J., Lin J.C., Delabarre L., et al. Detection of intracellular lactate with localized diffusion {1H-13C}-spectroscopy in rat glioma in vivo. J Magn Reson 177 1 (2005) 129-138
20. Demaerel P., Johannik K., Van Hecke P., et al. Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 15 1 (1991) 67-76
21. van Vaals J.J., Bergman A.H., van den Boogert H.J., et al. Non-invasive in vivo localized 1H spectroscopy of human astrocytoma implanted in rat brain: regional differences followed in time. NMR Biomed 4 3 (1991) 125-132
22. Gyngell M.L., Hoehn-Berlage M., Kloiber O., et al. Localized proton NMR spectroscopy of experimental gliomas in rat brain in vivo. NMR Biomed 5 6 (1992) 335-340
23. Ross B.D., Merkle H., Hendrich K., et al. Spatially localized in vivo 1H magnetic resonance spectroscopy of an intracerebral rat glioma. Magn Reson Med 23 1 (1992) 96-108
24. Gyngell M.L., Els T., Hoehn-Berlage M., et al. Proton MR spectroscopy of experimental brain tumors in vivo. Acta Neurochir Suppl (Wien) 60 (1994) 350-352
25. Chenevert T.L., Brunberg J.A., and Pipe J.G. Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 177 2 (1990) 401-405
26. Chenevert T.L., Meyer C.R., Moffat B.A., et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging 1 4 (2002) 336-343
27. Price S.J., Burnet N.G., Donovan T., et al. Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion?. Clin Radiol 58 6 (2003) 455-462
28. Lu S., Ahn D., Johnson G., et al. Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 232 1 (2004) 221-228
29. Wang W., Steward C.E., and Desmond P.M. Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L, and fractional anisotropy. AJNR Am J Neuroradiol 30 1 (2009) 203-208
30. Holodny A.I., and Ollenschlager M. Diffusion imaging in brain tumors. Neuroimaging Clin N Am 12 1 (2002) 107-124 x
31. Chenevert T.L., Sundgren P.C., and Ross B.D. Diffusion imaging: insight to cell status and cytoarchitecture. Neuroimaging Clin N Am 16 4 (2006) 619-632 viii-ix
32. Ross B.D., Chenevert T.L., Kim B., et al. Magnetic resonance imaging and spectroscopy: application to experimental neuro-oncology. Quart Magn Reson Biol Med Phys 1 (1994) 89-106
33. Chenevert T.L., McKeever P.E., and Ross B.D. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3 9 (1997) 1457-1466
34. Chenevert T.L., Stegman L.D., Taylor J.M., et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92 24 (2000) 2029-2036
35. Moffat B.A., Chenevert T.L., Lawrence T.S., et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 102 15 (2005) 5524-5529
36. Moffat B.A., Chenevert T.L., Meyer C.R., et al. The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia 8 4 (2006) 259-267
37. Meyer C.R., Moffat B.A., Kuszpit K.K., et al. A methodology for registration of a histological slide and in vivo MRI volume based on optimizing mutual information. Mol Imaging 5 1 (2006) 16-23
38. Basser P.J., Mattiello J., and LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 103 3 (1994) 247-254
39. Brunberg J.A., Chenevert T.L., McKeever P.E., et al. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 16 2 (1995) 361-371
40. Inglis B.A., Neubauer D., Yang L., et al. Diffusion tensor MR imaging and comparative histology of glioma engrafted in the rat spinal cord. AJNR Am J Neuroradiol 20 4 (1999) 713-716
41. Kim S., Pickup S., Hsu O., et al. Diffusion tensor MRI in rat models of invasive and well-demarcated brain tumors. NMR Biomed 21 3 (2008) 208-216
42. Lope-Piedrafita S., Garcia-Martin M.L., Galons J.P., et al. Longitudinal diffusion tensor imaging in a rat brain glioma model. NMR Biomed 21 8 (2008) 799-808
43. Basser P.J., Pajevic S., Pierpaoli C., et al. In vivo fiber tractography using DT-MRI data. Magn Reson Med 44 4 (2000) 625-632
44. Asanuma T., Doblas S., Tesiram Y.A., et al. Diffusion tensor imaging and fiber tractography of C6 rat glioma. J Magn Reson Imaging 28 3 (2008) 566-573
45. Vajkoczy P., and Menger M.D. Vascular microenvironment in gliomas. J Neurooncol 50 1-2 (2000) 99-108
46. Barrett T., Brechbiel M., Bernardo M., et al. MRI of tumor angiogenesis. J Magn Reson Imaging 26 2 (2007) 235-249
47. Batchelor T.T., Sorensen A.G., di Tomaso E., et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11 1 (2007) 83-95
48. Law M., Young R.J., Babb J.S., et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 247 2 (2008) 490-498
49. Steen R.G., Kromhout-Schiro S., and Graham M.M. Relationship of perfusion to edema in the 9L gliosarcoma. J Neurooncol 16 1 (1993) 81-87
50. Moffat B.A., Chenevert T.L., Hall D.E., et al. Continuous arterial spin labeling using a train of adiabatic inversion pulses. J Magn Reson Imaging 21 3 (2005) 290-296
51. Moffat B.A., Chen M., Kariaapper M.S., et al. Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D. Clin Cancer Res 12 5 (2006) 1525-1532